<b>MODY is prevalent in later-onset diabetes, has potential for targeted therapy but is challenging to identify</b>

<b>MODY is prevalent in later-onset diabetes, has potential for targeted therapy but is challenging to identify</b>

<p dir="ltr">Maturity Onset Diabetes of the Young (MODY) can present after the age of 40 years, but its prevalence, clinical characteristics, and the utility of simple clinical features for selecting cases in this age group remain poorly defined. We analysed whole-exome and clinical...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Hoofdauteur: Luke N Sharp (22551717) (author)
Andere auteurs: Uyenlinh L Mirshahi (22551718) (author), Kevin Colclough (422231) (author), Timothy S Hall (22551719) (author), Jeremy S Haley (22551721) (author), Stuart J Cannon (22551727) (author), Thomas W Laver (22551731) (author), Michael N Weedon (21698) (author), Andrew T Hattersley (21706) (author), David J Carey (22551733) (author), Kashyap A Patel (22551735) (author)
Gepubliceerd in: 2025
Onderwerpen:
Other biological sciences not elsewhere classified
Monogenic Diabetes
Maturity-Onset Diabetes of the Young (MODY)
Genetics & Genomics
Genetic Screening
Late Onset
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items